Analysed RAKOVINA THERAPEUTICS INC (RKVTF:OTCMKTS) News Sources
Rakovina Therapeutics Announces Closing of First Tranche, Upsize and Extension of Non-Brokered Private Placement
12-08-2026
yahoo.com
Rakovina Therapeutics Announces Final Closing of Upsized Non-Brokered Private Placement
31-08-2026
yahoo.com
Rakovina Therapeutics Announces Q2 2026 Financial Results and Provides Corporate Update
31-08-2026
yahoo.com
Rakovina Therapeutics Announces Appointment of Professor Petra Hamerlik to its Board of Directors
10-09-2026
yahoo.com
Rakovina Therapeutics Announces Appointment of New Scientific Advisory Board Member
17-09-2026
yahoo.com
Rakovina Therapeutics Partners with Boston-based Celvion Therapeutics to Leverage AI and Real-World Clinical Data for Precision Cancer Drug Development
01-10-2026
yahoo.com
Rakovina Therapeutics Secures Exclusivity on Optimized kt-5000 Lead Profile from Variational AI
14-10-2026
yahoo.com
Rakovina Therapeutics and Variational AI Advance Brain-Penetrant ATR Program Toward Development Candidate Selection
22-10-2026
yahoo.com
What is the current price of RAKOVINA THERAPEUTICS INC (RKVTF:OTCMKTS)?
The current price of RAKOVINA THERAPEUTICS INC (RKVTF:OTCMKTS) is $0.123.
RAKOVINA THERAPEUTICS INC (RKVTF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of RAKOVINA THERAPEUTICS INC (RKVTF:OTCMKTS) since the previous trading day is $0.
RAKOVINA THERAPEUTICS INC (RKVTF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of RAKOVINA THERAPEUTICS INC (RKVTF:OTCMKTS) since the previous trading day is 0%.
What is the most recent average sentiment score for RAKOVINA THERAPEUTICS INC (RKVTF:OTCMKTS)?
The most recent average sentiment score for RAKOVINA THERAPEUTICS INC (RKVTF:OTCMKTS) is 69 out of 100.
What is the most recent average sentiment for RAKOVINA THERAPEUTICS INC (RKVTF:OTCMKTS)?
The most recent sentiment for RAKOVINA THERAPEUTICS INC (RKVTF:OTCMKTS) is .
SEC-8K** Filing Available For RAKOVINA THERAPEUTICS INC (RKVTF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.